Sorin

Quick links to important sections

Sorin

Method of action: Miorelaxant

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sorin

Quick Facts

Property Description
Active Ingredient Chlorzoxazone
Form Oral Tablet
Pharmacological Class Centrally Acting Skeletal Muscle Relaxant (M03BB03)
General Purpose Symptomatic relief of acute muscle spasm
Origin Synthetic organic compound

What Type of Medicine is Sorin (Chlorzoxazone)?

The pharmaceutical entity Sorin contains the active ingredient Chlorzoxazone, which defines its classification as a Centrally Acting Skeletal Muscle Relaxant. This single-ingredient medication is a synthetic compound (C7H4ClNO2) and is presented as a standardized oral tablet, designed for the oral route of administration. The use of Chlorzoxazone in managing muscle spasm is clinically recognized and supported by pharmacological studies.

As a dedicated formulation, Sorin focuses solely on delivering Chlorzoxazone, which acts by influencing the Central Nervous System (CNS). This dedicated composition allows for a targeted central action, unlike certain other products that combine muscle relaxants with other pain-relieving agents.

Understanding the General Purpose of Sorin

The general purpose of Sorin (Chlorzoxazone) is to provide symptomatic relief from the pain and restricted movement that arise from acute, painful muscle spasm. It is utilized as an adjunct therapy, intended to support and complement core non-pharmacological treatments like physical therapy and rest during recovery.

By acting on the nerve-mediated overstimulation at the spinal cord, the medication helps reduce this involuntary contraction of the affected skeletal muscle fibers. This established mechanism is crucial for breaking the cycle of spasm and pain, contributing to an improved range of motion and overall functional recovery.

What side effects are possible with Sorin?

Possible Side Effects and Safety Information

Officially Documented Serious Adverse Reactions

The most serious safety concerns associated with this medication involve the potential for severe cardiovascular and central nervous system effects, as highlighted by governmental regulatory bodies. Sorin carries a Boxed Warning—the strongest warning required by the FDA—to alert prescribers and patients to the risk of serious, disabling, and potentially permanent adverse reactions.

Serious and Potentially Permanent Adverse Reactions:

System-Organ Class Serious Adverse Reactions (Examples)
Cardiovascular Serious cardiovascular thrombotic events (e.g., heart attack, stroke). Risk may begin early and increase with longer use and higher doses. Heart failure.
Musculoskeletal & Nervous Tendinitis, tendon rupture, and peripheral neuropathy (e.g., pain, numbness, tingling in the extremities). These effects can be disabling and may be permanent.
Central Nervous System Mental health changes, including anxiety, depression, confusion, hallucinations, and suicidal thoughts or actions.

Population-Specific Safety Considerations

The risk of serious side effects is not limited to any specific group, but it may be increased in patients with pre-existing heart disease or risk factors for heart disease. Patients treated with the drug class following a first heart attack were also found to have a higher likelihood of death in the first year after the event.

High-Level Safety Monitoring Notes

Official labeling advises that treatment should be stopped immediately if a serious adverse reaction occurs, and symptoms of heart attack, stroke, or severe musculoskeletal/nervous system distress (like unusual joint pain or muscle weakness) should prompt immediate medical attention. The drug is generally reserved for use when other treatment options are not available or are not tolerated, due to the magnitude of these risks.

Overdose and Emergency Response

Overdose and When to Seek Help

The regulatory profile for Sorin overdosage specifies known toxic manifestations and critical emergency protocols for management. Overdose may result in severe cardiovascular, neurological, or respiratory symptoms that can be life-threatening.

Documented Overdose Presentations

Official regulatory documents describe overdosage as potentially leading to specific signs and symptoms, including severe hypotension, marked bradycardia (abnormally slow heart rate), and significant prolongation of the QT interval. The major life-threatening outcome documented is Torsade de Pointes (TdP), a form of polymorphic ventricular tachycardia, which is associated with excessive QT prolongation.

Overdose presentations may be influenced by factors such as existing renal impairment or concomitant use of certain other substances. Population-specific warnings emphasize the need for caution in patients with reduced kidney function, as this can increase the drug's concentration and the risk of toxicity.

Required Emergency Response

The official instruction is to seek immediate medical help or contact a Poison Control Center at the first suspicion of an overdose. Overdose management requires supportive treatment, often including careful monitoring of vital signs and continuous electrocardiographic observation in a facility capable of cardiac resuscitation.

There is no specific pharmacological antidote officially listed to reverse all effects of Sorin overdose; therefore, management focuses on supportive and symptomatic measures, such as addressing hypotension and treating bradycardia with appropriate interventions. Any clinical sign suggesting cardiac instability or severe central nervous system effects requires urgent professional medical intervention.

Therapeutic Uses of Sorin

What Sorin Treats: Main Uses and Benefits

This medication is commonly used to help with symptoms related to acute, painful musculoskeletal conditions, such as muscle strains, sprains, and other short-term issues presenting with muscle tightening. Its primary application is relevant for managing symptoms of increased muscular activity that involve painful skeletal muscle spasm and the resulting stiffness.

Sorin is generally considered relevant when supportive symptom management is appropriate, as it is used as an adjunct to rest and physical therapy. Applied across domains where additional symptomatic support is needed, it helps address symptoms during difficult episodes and contributes to easing the overall symptom load. By helping to reduce the intensity of muscle tightening, it provides supportive relief when symptoms interfere with routine activities.

“It is commonly used across conditions presenting with acute episodes, where symptomatic support may assist in managing functional comfort.”

Quick Fact: Relief for Acute Muscle Symptoms
Focus Painful muscle spasm and resulting stiffness
Clinical Context Adjunct therapy for acute musculoskeletal conditions
Primary Benefit Contributes to easing day-to-day discomfort and assists with mobility

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Sorin (Chlorzoxazone)?

This section outlines the officially documented population eligibility rules for Sorin, based strictly on government regulatory labeling. Eligibility is defined by age, reproductive status, and specific pre-existing conditions.


Populations That Must Not Use Sorin (Contraindications)

Category Regulatory Status
Hypersensitivity Contraindicated in patients with known intolerance to the drug or any component of the formulation.

Age-Group and Condition Restrictions

Population Group Labeled Status or Restriction
Adults Established as the primary approved population.
Pediatric Patients Safety and efficacy have not been established.
Liver Impairment Must be used with caution in patients with pre-existing liver disease. Discontinuation is mandated if symptoms of liver dysfunction develop.
Geriatric Patients Caution may be required due to a higher likelihood of age-related liver problems.
Renal Impairment No evidence of drug-induced renal damage documented in the label.

Pregnancy and Lactation Eligibility

  • Pregnancy: Safe use has not been established with respect to possible adverse effects upon fetal development. Use is restricted to women of childbearing potential only when the potential benefits outweigh the possible risks.
  • Lactation: Data on excretion into human milk is not available. The potential benefits must be weighed against potential risks.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the interaction profile of Sorin (Chlorzoxazone) primarily across two pharmacological domains that require specific caution during co-administration.

Documented Interaction Patterns

Interaction Type Interacting Substances/Classes Official Description
Pharmacodynamic Alcohol, CNS Depressants (e.g., Opioids) Co-administration may produce an additive CNS depressant effect, increasing the risk of outcomes like sedation and impairment.
Pharmacokinetic CYP2E1 Inhibitors (e.g., Isoniazid, Watercress) Co-administration is associated with a documented increase in the plasma concentration (exposure) of Chlorzoxazone, as the drug is metabolized by CYP2E1.
Enzyme Inhibition CYP3A4 Substrates Chlorzoxazone itself has been found to act as a CYP3A4 inhibitor, which may alter the exposure of other co-administered medicines metabolized by this pathway.

Interaction-Related Restrictions and Cautions

No specific drug-drug combinations are labeled as absolute contraindications due to interaction risk in core prescribing information. However, co-administration with alcohol and other CNS depressants must be noted due to the high likelihood of additive effects. Administration of Sorin requires caution in patients with pre-existing hepatic impairment because this condition may heighten the risk of adverse outcomes related to the drug's metabolic pathway and potential accumulation. No mandatory administration-timing separation rules are explicitly documented in core regulatory labeling.

Mechanism of Action

How Sorin Works: Mechanism of Action


1. Primary Target: Inhibition of Serine Proteases

Sorin primarily acts as an inhibitor by targeting the catalytic activity of various serine proteases , forming a stable intermediate with the enzyme's active site. This mechanism is central to modulating biological processes that rely on the enzymatic activation carried out by these specific proteins, influencing downstream signaling.


2. Dual Pathway Modulation

This mechanism exerts influence across two critical systems. First, in the coagulation cascade, Sorin disrupts the sequential activation of proteases necessary for the process. Inhibiting these enzymatic steps reduces the generation of clotting factors, resulting in the physiological consequence of modulated coagulation and delayed blood clotting time.

Simultaneously, Sorin engages mechanisms that modulate pathways associated with elevated inflammatory responses. By limiting the activity of specific proteases that trigger receptor activation and the release of pro-inflammatory mediators, the drug reduces excessive cellular signaling. This combined effect results in a systemic anti-inflammatory state and constitutes the core biological driver behind the drug’s overall mechanistic consequences.

Dosage and Administration Information

How Sorin (Chlorzoxazone) is Used: Official Administration Guidelines

Sorin, which contains Chlorzoxazone, is supplied as an oral tablet and must be taken by mouth. The medication is officially designated as an adjunct to rest and physical therapy, intended for use only in the context of acute painful musculoskeletal conditions.


Standard Dosing and Administration

Feature Guideline
Administration Route Oral (by mouth)
Frequency Pattern Three or four times daily (q6-8h)
Adult Dosing Range Initial dose: 250 mg to 500 mg. May be increased to 750 mg per dose for inadequate response
Food Relationship May be taken with or without food. Can be taken with food or milk if gastric upset occurs

Procedural Usage Rules

The usage protocol is response-driven. As clinical improvement occurs, the official instruction is to reduce the dose to the lowest amount that maintains relief. The maximum dose typically administered is 750 mg per administration.

Regarding the handling of missed doses, if a dose is skipped, it should be taken as soon as possible unless it is almost time for the next scheduled dose, in which case the missed dose should be skipped; doses must not be doubled.

Special Populations: The safety and efficacy of the medication have not been established in the pediatric population. For older adults, caution and consideration for a lower starting dose may be advised.

Recent Clinical Evidence

Research evidence / Overview of studies for Sorin

Research Evidence for Acute Muscle Discomfort

The clinical evaluation for the use of Sorin was studied for its use in contexts associated with discomfort in acute, painful musculoskeletal conditions, such as short-term muscle spasms or strains. Research in this area has relied on controlled study designs, particularly Randomized Controlled Trials (RCTs). These short-term RCTs were used to evaluate Sorin's active ingredient against an inactive placebo, and against other treatments evaluated in similar research settings. These studies were used in research exploring how symptoms change over time during a short-lived episode of muscle pain.

The findings from these controlled trials and the systematic reviews that have compiled their results contribute to the broader evidence landscape for skeletal muscle relaxants. The evidence describes patterns observed in the studies that were designed to examine outcomes related to physical discomfort and outcomes describing episodic or acute changes. However, authoritative sources note that evidence quality varies across studies within this class of medication, and the overall consistency of findings can be limited.

What Outcomes Were Measured in Clinical Trials

In studies involving patients with conditions characterized by fluctuating or episodic manifestations of muscle discomfort, researchers concentrated on specific, measurable patient-reported outcomes describing perceived discomfort. The main outcomes that were evaluated in the research included precise measurements of pain intensity and the degree of muscle tightening or resulting stiffness.

Research also examined outcomes reflecting daily functioning or activity level, such as changes in the patient's range of motion or their ability to engage in routine physical activities during the short study period. Findings help contextualize how patients reported their experience during this acute phase.

Study Duration and Long-Term Follow-up

The trials evaluating Sorin were conducted during periods of increased symptom activity and were designed to study outcomes during acute episodes. This duration reflects the context of research for adjunctive therapy for short-term issues. Studies exploring whether the initial changes measured during the study period are sustained over many months, or whether the research focus expands to chronic conditions, are generally lacking in the existing evidence base.

Evidence in Specific Patient Groups

The core body of research evaluated the active ingredient in generally healthy adults who were experiencing acute musculoskeletal pain. Data for certain groups remain insufficient; for instance, there is limited information for special populations, such as pediatric patients or older adults, regarding the study of this medicine in these groups. Therefore, results apply only to the populations studied in the research that has been published so far.

The Current Scientific View on Evidence Limitations and Gaps

Official scientific literature highlights several aspects where certainty remains low or evidence is limited regarding the use of Sorin. One key limitation is that sample sizes were modest in some of the reviewed trials, which contributes to variability in the findings. Furthermore, research explored short-term symptom changes, meaning longer-term outcomes are not well characterized. The evidence for the use of the active ingredient in non-primary indications, such as managing pain after major joint surgery, has been studied for, but the reported outcomes varied across trials in those specific contexts.

Key Studies & References

  1. Drug Class Review on Skeletal Muscle Relaxants for Spasticity and Musculoskeletal Conditions (Final Report and Evidence Tables)

Frequently Asked Questions (FAQ)

Common questions about Sorin (FAQ)

Q: What are the most common side effects people report when taking Sorin?

Official product information indicates that the most commonly reported effects of Sorin (Chlorzoxazone) are central nervous system effects such as drowsiness and dizziness. Gastrointestinal issues like upset stomach may also occur. These are the general expected effects documented in regulatory labeling.

Q: Is it common to feel tired or dizzy when starting Sorin?

Yes, regulatory documents note that drowsiness and dizziness are among the common effects associated with Sorin (Chlorzoxazone). As a centrally acting drug, it can influence alertness. Concerns regarding severe or persistent effects should be discussed with a healthcare provider.

Q: Are headaches a known side effect of Sorin?

Headaches are not consistently listed among the most frequent adverse effects in official prescribing information. However, individual experiences with any medication can vary. Official documentation prominently lists effects such as drowsiness and gastrointestinal issues.

Q: Can Sorin affect my mood or sleep patterns?

As a central nervous system (CNS) depressant, Sorin can cause drowsiness, which may affect sleep patterns. Regulatory information also notes that rare patients may experience nervousness or confusion. Severe changes in mood or sleep should be reviewed by a healthcare provider.

Q: What types of over-the-counter medications might interact with Sorin?

Official labeling advises caution when combining Sorin with any medication that causes drowsiness. This includes many common over-the-counter cold medicines or pain relievers that have a sedating effect. The presence of CNS depressants in OTC drugs is a key factor to review in combination with Sorin.

Q: What food or beverages should be avoided when using Sorin?

Official regulatory warnings emphasize that alcohol should be avoided due to the high risk of an additive CNS depressant effect, which increases sedation and impairment. Some specific foods, such as watercress, may also be noted in labeling as potential enzyme inhibitors that could affect how the body processes the drug.

Q: Is it possible to develop a tolerance to Sorin over time?

Official regulatory text discusses reducing the dose as clinical improvement occurs, which suggests the medication is intended for short-term use. While the development of tolerance is not typically detailed in general patient information, the drug is not classified as a controlled substance with a high risk of abuse.

Q: What does 'use conditions' mean for a drug like Sorin?

Use conditions refer to the specific context in which a medicine is officially indicated. For Sorin, the condition of use is as an adjunct (meaning in addition to) rest and physical therapy, exclusively for acute (short-term) painful musculoskeletal conditions. It is not intended for long-term use.

Q: Is Sorin considered a first-line treatment for the condition it addresses?

Official regulatory documents indicate that Sorin is intended to be used as an adjunct therapy to rest and physical therapy. This means it is meant to supplement core, non-pharmacological treatments, rather than serving as the initial, first-line intervention for the management of acute muscle discomfort.

Q: How is Sorin different from [similar drug name]? (No superiority claims)

Sorin is classified as a centrally acting skeletal muscle relaxant. This means it works by inhibiting nerve reflexes primarily within the spinal cord and lower brain regions. This targeted action is a key pharmacological feature that differentiates it from other drugs used for muscle discomfort.

Q: How quickly do the effects of Sorin usually start to appear?

Pharmacokinetic data suggests that the active ingredient can be detected in the body within the first 30 minutes following oral administration. The peak concentration in the body is typically reached within about one to two hours after taking the tablet.

Q: How long does Sorin stay in the body after the last dose?

Sorin is characterized by rapid metabolism, meaning the body breaks it down quickly. Regulatory information notes that less than one percent of the unchanged drug is excreted in the urine within 24 hours, indicating fast clearance from the system.

Q: How is Sorin eliminated from the body?

The drug is processed primarily by the liver, where it is broken down into inactive compounds. These metabolized substances are then mostly eliminated from the body through the urine.

Q: Is Sorin habit-forming or addictive?

The active ingredient in Sorin, Chlorzoxazone, is not classified as a controlled substance by the U.S. Drug Enforcement Administration (DEA). However, because it acts on the central nervous system, the use of the medication should strictly follow the directions provided by a healthcare provider.

Q: How does Sorin affect blood pressure or heart rate?

Official regulatory documents do not suggest that Sorin is routinely used to manage blood pressure or heart rate. However, extreme reactions or overdosage have shown effects on the circulatory system, including low blood pressure. It is not generally expected to cause routine changes in these vital signs.

Q: Is there a generic version of Sorin available?

Yes, Sorin's active ingredient, Chlorzoxazone, is widely available in generic form. It has been approved by the FDA under an Abbreviated New Drug Application (ANDA), indicating its status as a pharmaceutical equivalent to the brand name product.

Q: Can I drive or operate machinery while taking Sorin?

Official prescribing information advises caution regarding activities requiring full mental alertness. Because Sorin may cause drowsiness or dizziness, patients are generally advised to understand how the medication affects them before engaging in activities that require full attention, such as driving or operating hazardous machinery.

Q: Are allergic reactions to Sorin common?

Official reports indicate that allergic-type skin reactions, such as rashes, are possible but not common. More serious reactions like anaphylaxis are extremely rare. A known allergy or hypersensitivity to the drug is listed as a contraindication.

Q: Does Sorin contain lactose, gluten, or other common allergens?

Some formulations of Sorin (Chlorzoxazone) tablets are documented to contain inactive ingredients such as lactose monohydrate. Patients with specific sensitivities should review the full list of inactive ingredients on the product's package insert.

Q: Is it normal to have a dry mouth while using Sorin?

Dry mouth is not listed among the most frequently reported side effects in the primary regulatory documentation for Sorin. The documentation prioritizes common effects like dizziness, drowsiness, and stomach upset.

Q: Does Sorin show up on drug tests?

Sorin (Chlorzoxazone) is generally not included in standard drug screening panels due to its rapid metabolism and excretion. However, specific drug tests can detect the medication or its metabolites in the body.

How should Sorin be stored and disposed of?

How to Store and Dispose of Sorin (Chlorzoxazone)

The official labeling for Sorin (Chlorzoxazone) defines specific conditions for storage and disposal to maintain product stability and safety.

Storage Requirements

Condition Regulatory Mandate
Temperature Store at Controlled Room Temperature (20^circ to 25 C or 68^circ to 77 F).
Container Must be kept in a tight container to protect contents from moisture.
Child Safety Keep the medicine out of the reach of children at all times.

Disposal Instructions

Unused or expired Sorin tablets should be disposed of through a drug take-back program or mail-back service when available, as recommended by official guidance. The drug is not on the list of medications approved for flushing down the toilet. If take-back is not possible, household disposal involves mixing the tablets with an undesirable substance and placing the mixture in a sealed container before throwing it into the trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sorin found in:

A-Z Index: